SLC13A5 and metabolic disease: Genetically reduced INDY expression has beneficial effects on metabolism and prevents diet-induced obesity in flies and mice, suggesting INDY as a target in the treatment of metabolic disorders in humans (Wang et al., 2009; Birkenfeld et al., 2011; Rogers and Rogina, 2015).